(1)
Reich, K.; Blauvelt, A.; Lebwohl, M.; Papp, K.; Rich, P.; Strober, B.; De Cuyper, D.; Madden, C.; Peterson, L.; Vanvoorden, V.; Warren, R. Bimekizumab Safety in Patients With Moderate to Severe Psoriasis: Analysis of Pooled Data from Phase 2 and 3 Clinical Trials. J of Skin 2021, 5, s21.